Breakthrough T1D has updated this opportunity to focus exclusively on the Industry Discovery & Development Partnership (IDDP) program, meaning lead applicants must now be for-profit organizations. Maximum funding has decreased from $3 million to $1.5 million over three years. On the plus side, deadlines are now rolling, allowing you to submit inquiries and letters of intent year-round.
Funder: Breakthrough T1D
Due Dates: Rolling (inquiries accepted year-round)
Funding Amounts: Typically up to $1,500,000 total over 3 years; larger budgets considered with strong justification.
Summary: Supports for-profit organizations advancing research and development of innovative type 1 diabetes therapies aligned with Breakthrough T1D’s priorities.
Key Information: Company matching funds required; indirect costs are not permitted.